Avalo Therapeutics Inc. (AVTX)
NASDAQ: AVTX
· Real-Time Price · USD
3.96
0.10 (2.59%)
At close: May 16, 2025, 3:59 PM
3.91
-1.26%
After-hours: May 16, 2025, 05:49 PM EDT
2.59% (1D)
| Bid | 3.75 |
| Market Cap | 42.88M |
| Revenue (ttm) | 441K |
| Net Income (ttm) | 86.16M |
| EPS (ttm) | -20.91 |
| PE Ratio (ttm) | -0.19 |
| Forward PE | -0.91 |
| Analyst | Buy |
| Ask | 4.47 |
| Volume | 81,834 |
| Avg. Volume (20D) | 73,308 |
| Open | 3.88 |
| Previous Close | 3.86 |
| Day's Range | 3.87 - 4.21 |
| 52-Week Range | 3.39 - 16.00 |
| Beta | 0.88 |
About AVTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AVTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AVTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+11.93%
Avalo Therapeutics shares are trading higher after...
Unlock content with
Pro Subscription
8 months ago
+8.88%
Avalo Therapeutics shares are trading higher after BVF Partners disclosed in a 13G filing that it reported a 9.99% stake in the company.
